Product Program year 2025 Source: CMS Open Payments

Advantage System

Device Advantage_URO

PDI 08714729470274

Open in the dashboard

General payments

$373,680

2,952 payments

Research payments

$7,500

1 payment

Through program year 2025, $373,680 in general payments and $7,500 in research payments were reported against Advantage System (Advantage_URO).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $152,907 469
2025 Research $7,500 1
2024 General $56,641 948
2023 General $31,638 632
2022 General $132,494 903

Breakdown

Who paid General payments · program years 2022–2025
  1. Boston Scientific Corporation $373,680 2,952 payments
Top recipients General payments · program year 2025
  1. Dara Shalom Urogynecology and Reconstructive Pelvic Surgery · Great Neck, NY $23,718 16% · 9 payments
  2. Brent Parnell Urogynecology and Reconstructive Pelvic Surgery · Birmingham, AL $13,630 9% · 7 payments
  3. David Lovejoy Urogynecology and Reconstructive Pelvic Surgery · Macon, GA $10,751 7% · 5 payments
  4. Jannah Thompson Urogynecology and Reconstructive Pelvic Surgery · Norton Shores, MI $10,651 7% · 9 payments
  5. Thomas Giudice Urogynecology and Reconstructive Pelvic Surgery · West Columbia, SC $10,396 7% · 5 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Urogynecology and Reconstructive Pelvic Surgery Obstetrics & Gynecology $101,564 67% · 98 practitioners
  2. Urology $20,952 14% · 58 practitioners
  3. Urogynecology and Reconstructive Pelvic Surgery Urology $19,147 13% · 8 practitioners
  4. Obstetrics & Gynecology $5,326 4% · 54 practitioners
  5. Surgery $760 <1% · 1 practitioner

The top 5 of 26 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. New York $24,205 16% · 7 recipients
  2. California $23,367 15% · 29 recipients
  3. Florida $14,161 9% · 25 recipients
  4. Alabama $13,753 9% · 4 recipients
  5. Georgia $11,942 8% · 46 recipients

The top 5 of 36 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

2,952 general · 1 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record